COVID-19 Clinical Guidelines–Laboratory
If we can assist your organization in the battle against COVID-19, whether or not you are a current member, please contact us today at clientservices@ecri.org.
Laboratory biosafety guidance related to coronavirus disease (COVID-19): interim guidance
Date: 2021 Jan 28
Developer: World Health Organization (WHO)
Guideline Focus
Laboratory biosafety related to COVID-19 and the testing of clinical specimens
Patient Population
Patients that meet the case definition of coronavirus disease (COVID-19)
Major Interventions
- Risk assessment of laboratory processes, implementation toolkit, and referral of specimens to laboratories with appropriate risk control measures
- Performance of routine laboratory procedures and point of care assays
- Use of appropriate disinfectants
- Viral isolation procedures and precautions
- Considerations for work with infected animals
- Packaging and shipment of materials
Diagnostic testing for SARS-CoV-2: interim guidance
Date: 2020 Sep 11
Developer: World Health Organization (WHO)
Guideline Focus
Diagnostic testing for COVID-19
Patient Population
Patients with suspected COVID-19, and laboratory personnel
Major Interventions
- Factors influencing testing decisions
- Appropriate specimen collection, storage, and transport
- Laboratory testing options and algorithm, including nucleic acid amplification testing (NAAT) and serologic testing
- Adherence to reporting requirements and quality assurance